Exactis Innovation is pleased to formally announce the launch of the Exactis Innovation Investigator-Initiated Trial (IIT) Grant Competition.
In alignment with the Exactis Mission to accelerate precision oncology by matching specific molecular or clinical profiles to novel treatments available through clinical trials, the Exactis IIT Grant Competition will provide $CDN 1 million to a team of Exactis Network Investigators to help support a Phase I or II interventional precision oncology study evaluating a compelling targeted therapy or immunotherapy based on molecularly or clinically defined populations in at least one of the Exactis “Personalize My Therapy” Patient Cohorts.
Letters of Intent are due February 28th, 2019.
For additional information and to obtain the necessary forms please contact Andrew Slack (aslack@exactis.ca)
Best wishes to all applicants!